THOUSAND OAKS, Calif. Amgen reported on its third quarter earnings for 2007, which saw adjusted earnings per share, excluding stock option expense and certain other expenses of $1.08.
This is an increase of 4 percent compared to the third quarter of 2006. The adjusted net income decreased by 4 percent to $1.181 billion compared to $1.224 billion in the third quarter last year.
Total revenue remained the same at $3.6 billion when compared to the third quarter of 2006. The company’s anemia franchise saw products sales decrease by 16 percent.